MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma
{{output}}
Background: Determining failure to anti-angiogenic therapy in recurrent glioblastoma (GBM) (rGBM) remains a challenge. The purpose of the study was to assess treatment response to bevacizumab-based therapy in patients with rGBM u... ...
